Skip to main content
. 2021 May 5;41(10):2524–2533. doi: 10.1177/0271678X211012110

Figure 2.

Figure 2.

Plasma lipocalin-2 (LCN2) levels and SAH functional outcomes at 3-month (a) and 6-month (b) and plasma lipocalin-2 levels relative to SAH clinical severity measured by Hunt Hess grade (c) and radiographic severity measured by modified Fisher grade (d) (#p < 0.05, ### p < 0.001). All data are presented as mean ± standard deviation (SD).